Health Care & Life Sciences » Pharmaceuticals | Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.82
Market Cap
$261.63 M
Shares Outstanding
25.75 M
Public Float
22.79 M

Profile

Address
3650 Gilmore Way
Burnaby British Columbia V5G 4W8
Canada
Employees -
Website http://www.xenon-pharma.com
Updated 07/08/2019
Xenon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in discovering and developing a pipeline of differentiated therapeutics. It has built a core enabling discovery platform for the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies.

Financials

View All

Simon Neil Pimstone
Chief Executive Officer & Director
Michael M. Tarnow
Chairman